IP Library Granted Patent US 8,328,776
Granted Patent B2
US 8,328,776 · App. 12/824,582 · Granted Dec 11, 2012

Reduced pressure treatment system having blockage clearing and dual-zone pressure protection capabilities

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,328,776
App. No.
12/824,582
Granted
Dec 11, 2012
Kind
B2
Abstract

A method of treating a tissue site is provided. The method includes applying a reduced pressure to a tissue site with a reduced pressure source. A source pressure is monitored at the reduced pressure source, and a differential pressure is determined between the source pressure and the desired tissue site pressure. If a blockage is present between the reduced pressure source and the tissue site, the differential pressure is limited to a first maximum differential pressure. If no blockage is present between the reduced pressure source and the tissue site, the differential pressure is limited to a second maximum differential pressure.

Claims (20)

1. A method of treating a tissue site comprising:

applying a reduced pressure to a tissue site with a reduced pressure source;

monitoring a source pressure at the reduced pressure source;

determining a differential pressure between the source pressure and the desired tissue site pressure;

if a blockage is present between the reduced pressure source and the tissue site, limiting the differential pressure to a first maximum differential pressure; and

if no blockage is present between the reduced pressure source and the tissue site, limiting the differential pressure to a second maximum differential pressure, wherein the second maximum differential pressure is greater than the first maximum differential pressure.

2. The method according to claim 1 , wherein the first maximum differential pressure is about 50 mm Hg.

3. The method according to claim 1 , wherein the second maximum differential pressure is about 100 mm Hg.

4. The method according to claim 1 , wherein the step of determining the differential pressure further comprises monitoring the differential pressure.

5. The method according to claim 1 further comprising:

when a blockage is present, increasing the source pressure, within the limits of the first maximum differential pressure, to attempt to clear the blockage.

6. The method according to claim 1 further comprising:

when a blockage is present, increasing the source pressure, within the limits of the first maximum differential pressure, to attempt to clear the blockage; and

if the blockage does not clear, generating an alarm to indicate that a blockage is present.

7. The method according to claim 1 further comprising:

changing the source pressure, within the limits of one of the first and second maximum differential pressures, to cause a pressure at the tissue site to reach a desired tissue site pressure.

8. The method according to claim 1 further comprising:

determining if a blockage is present by changing the source pressure and monitoring for a directionally corresponding change in a pressure at the tissue site; and

determining that a blockage is present when no directionally corresponding change occurs in the pressure at the tissue site.

9. The method according to claim 8 , wherein changing the source pressure further comprises increasing the source pressure.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066430/0333 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064790/0085 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2014
From: KELCH, RANDALL P.; ZHENG, XIAOLU; EDGAR, JR., REUBEN W.; JAEB, JONATHAN PAUL; LAWHORN, THOMAS PAUL; INGRAM, SHANNON C.
To: KCI LICENSING, INC.
Reel/Frame 033700/0246 →